COLEXA BIOSENSOR PIPELINE
In the heart of Colexa’s journey lies an unwavering commitment to innovation, excellence, and meaningful impact. As we venture into the future, our pipeline and expansion plans echo this dedication, forging new horizons and setting new standards in healthcare technology.
OnPoint and Codeline Unveilings
This year marks the introduction of two powerful additions to our portfolio. With ‘OnPoint,’ our blood glucose strips and meters redefine quality and accessibility. Meanwhile, our anticipated ‘Codeline’ brand, poised for launch from the Colexa Biosensor factory, aligns with WHO standards. This African brand will address critical needs in rapid diagnostic testing, reflecting our dedication to homegrown solutions.
Accelerating RDTs
To bridge existing gaps in rapid diagnostic testing, we’re embracing a strategic approach. Initially, we’re producing the WHO pre-qualified ‘Standard Q’ RDTs as a steppingstone. Our goal? A definitive shift towards ‘Codeline,’ a homegrown brand that meets the exacting demands of international donors. This marks a pivotal move towards achieving African autonomy in healthcare solutions.
Codix-Bio Ltd: The Future Unveiled
A landmark achievement lies ahead with our technical partnership with SD Biosensor. This visionary project in Ogun State reflects our determination to take the lead in RDT manufacturing. With government approvals underway, construction is anticipated to commence in Q4 2023. By Q4 2024, this advanced manufacturing facility will stand tall, ushering in a new era of healthcare technology.
Our unwavering focus is on completing the factory by 2024, a milestone that will cement our leadership in RDT manufacturing and elevate healthcare accessibility across the continent.
Colexa’s pipeline and expansion plans encapsulate our passion for innovation and our resolute dedication to addressing pressing healthcare challenges. We are shaping a future where healthcare knows no bounds by advancing our technology, creating African solutions, and embracing strategic collaborations.
